Vimseltinib

N/A

Report date: 2026/05/06 20:02:28
NME

Base Information

Drug NameVimseltinib
Drug Alias NameROMVIMZADCC-3014DP-6865
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionColony stimulating factor 1 receptor inhibitors
TargetsColony stimulating factor 1 receptor
Therapy Area/IndicationsGraft vs Host DiseaseSynovitis, Pigmented VillonodularGiant Cell Tumor of Tendon Sheath +[4] 
Global Approved IndicationsGiant Cell Tumor of Tendon Sheath
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2025/02/14
Country/TerritoryCanadaUnited StatesPoland +[14] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDeciphera Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesDeciphera PharmaceuticalsDeciphera Pharmaceuticals IncDeciphera Pharmaceuticals (Netherlands) BV +[4] 
Inactive CompaniesN/A
Active IndicationsGraft vs Host DiseaseSynovitis, Pigmented VillonodularGiant Cell Tumor of Tendon Sheath
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A